Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner
Advanced Science · 2026-08 · 13 (47)
DOI: 10.1002/advs.202517222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.05.2026. Verfasst von Wei Zhang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Canagliflozin, Gastrointestinal Microbiome, Kidney Glomerulus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Henan Province, Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Canagliflozin reduces albuminuria in patients with diabetic kidney disease (DKD) beyond its glucose‐lowering effect, but the mechanisms remain unclear. We analyzed 85 patients treated with canagliflozin and 85 controls over 26 weeks to explore whether the gut microbiome and its metabolites contribute to renoprotection. Canagliflozin remodeled the gut microbiota, notably enriching Roseburia intestinalis and increasing plasma melibiose levels. In mice, canagliflozin alleviated glomerular endothelial injury and albuminuria. Similar effects were replicated by fecal microbiota transplantation, Roseburia intestinalis , or melibiose administration. Mechanistically, melibiose bound to and activated glyoxalase 1, reduced methylglyoxal, and suppressed the AGE‐RAGE pathway, preserving glomerular endothelial integrity. Furthermore, oral melibiose precursor supplementation reduced albuminuria in patients with early‐stage DKD. These findings suggest the involvement of a gut‐kidney axis in the renoprotective effects of canagliflozin and indicate that melibiose may serve as a potential therapeutic strategy for DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou, China.
- Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Endocrinology and Metabolism, Hebi Coal Industry (Group) Co., Ltd, General Hospital, Hebi, China.
- Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Endocrinology and Metabolism, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
ORCID-Profile: Wei Zhang, Guijun Qin
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Henan Province
- Natural Science Foundation of Henan Province
- Henan Joint Construction Program
- Science and Technology Research Project of Henan Province
Zitieren
APA
Zhang, W., Song, Y., Li, C., Luo, Y., Shao, M., Guo, F., Wei, F., Fan, X., Guo, W., Xu, F., Sang, Y., Zhang, D., Zhou, Y., Wang, L., Kang, Z., Yang, Y., Song, C., Liu, Y., Ma, X., …, & Qin, G. (2026). Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner. Advanced Science, 13(47). https://doi.org/10.1002/advs.202517222
Vancouver
Zhang W, Song Y, Li C, Luo Y, Shao M, Guo F, et al. Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner. Advanced Science. 2026;13(47). doi:10.1002/advs.202517222
BibTeX
@article{Zhang2026,
author = {Zhang, Wei and Song, Yi and Li, Changkun and Luo, Yuanyuan and Shao, Mingwei and Guo, Feng and Wei, Fangyi and Fan, Xunjie and Guo, Wenwen and Xu, Fengmei and Sang, Yanhong and Zhang, Dongming and Zhou, Yanhong and Wang, Lianwei and Kang, Zhiqiang and Yang, Yingjun and Song, Chunhua and Liu, Yanxia and Ma, Xiaojun and Wang, Jiao and Li, Chong and Ma, Shengnan and Zhao, Lin and Qin, Zhi and Xing, Guolan and Zhao, Qiubo and Li, Jun and Song, Shumin and Zhao, Dan and Huang, Ting and Wang, Qingzhu and Zhao, Yanyan and Qin, Guijun},
title = {Canagliflozin Alleviates Diabetic Glomerular Endothelial Injury via Melibiose in a Microbiota‐Dependent Manner},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {47},
doi = {10.1002/advs.202517222}
}
EUVIMED